PatientsVille.com Logo

PatientsVille

Carbon Side Effects

Common Carbon Side Effects


The most commonly reported Carbon side effects (click to view or check a box to report):

Completed Suicide (7)
Subcutaneous Emphysema (5)
Cardio-respiratory Arrest (5)
Post Procedural Complication (5)
Cardiac Arrest (4)
Hypotension (3)
Pneumomediastinum (3)
Carbon Monoxide Poisoning (3)
Vomiting (2)
Respiratory Arrest (2)
Air Embolism (2)
Intestinal Ischaemia (2)
Thermal Burn (2)
Abasia (1)
Abdominal Adhesions (1)
Abdominal Pain Upper (1)
Atrial Fibrillation (1)
Colitis Ischaemic (1)
Circulatory Collapse (1)
Acute Abdomen (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Carbon Side Effects Reported to FDA

The following Carbon reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Carbon on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Pneumomediastinum, Subcutaneous Emphysema, Post Procedural Complication
This is a report of a 76-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: laparoscopy, who was treated with Carbon Dioxide (dosage: Intraperitoneal, start time: NS), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Pneumomediastinum
  • Subcutaneous Emphysema
  • Post Procedural Complication
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Carbon Dioxide treatment in female patients, resulting in pneumomediastinum side effect.

Dysaesthesia, Muscle Contracture, Subcutaneous Emphysema
This report suggests a potential Carbon Dioxide Dysaesthesia, Muscle Contracture, Subcutaneous Emphysema side effect(s) that can have serious consequences. A 43-year-old female patient (weight: NA) from CH was diagnosed with the following symptoms/conditions: skin infection,off label use and used Carbon Dioxide (dosage: NA) starting NS. Soon after starting Carbon Dioxide the patient began experiencing various side effects, including:
  • Dysaesthesia
  • Muscle Contracture
  • Subcutaneous Emphysema
Drugs used concurrently: NA.The patient was hospitalized. Although Carbon Dioxide demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as dysaesthesia, may still occur.

Pneumomediastinum, Post Procedural Complication, Subcutaneous Emphysema
This Pneumomediastinum, Post Procedural Complication, Subcutaneous Emphysema problem was reported by a health professional from COUNTRY NOT SPECIFIED. A 65-year-old patient (weight: NA) was diagnosed with the following symptoms/conditions: laparoscopic surgery. On NS this consumer started treatment with Carbon Dioxide (dosage: NA). The following drugs were being taken at the same time:
  • (metoclopramide)
  • (ondansetron)
  • (dexamethasone)
When commencing Carbon Dioxide, the patient experienced the following unwanted symptoms/side effects:
  • Pneumomediastinum
  • Post Procedural Complication
  • Subcutaneous Emphysema
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as pneumomediastinum, may become evident only after a product is in use by the general population.

Circulatory Collapse, Cardiac Arrest, Ventricular Fibrillation, Electrocardiogram St Segment Elevation, Paradoxical Embolism, Right Ventricular Dysfunction, Dilatation Atrial, Ejection Fraction Decreased
This is a report of a 43-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: laparoscopy and was treated with Carbon Dioxide (dosage: Insufflation) starting NS. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Circulatory Collapse
  • Cardiac Arrest
  • Ventricular Fibrillation
  • Electrocardiogram St Segment Elevation
  • Paradoxical Embolism
  • Right Ventricular Dysfunction
  • Dilatation Atrial
  • Ejection Fraction Decreased
The patient was hospitalized. This opens a possibility that Carbon Dioxide treatment could cause the above reactions, including circulatory collapse, and some female subjects may be more susceptible.


Crepitations, Subcutaneous Emphysema, Hypercapnia
A 37-year-old female patient (weight: NA) from US with the following symptoms/conditions: laparoscopic surgery started Carbon Dioxide treatment (dosage: NA) on NS. Soon after starting Carbon Dioxide treatment, the subject experienced various side effects, including:
  • Crepitations
  • Subcutaneous Emphysema
  • Hypercapnia
Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Carbon Dioxide.

Respiratory Acidosis
A 26-year-old female patient from CA (weight: NA) experienced symptoms, such as: laparoscopy and was treated with Carbon Dioxide(dosage: NA). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Respiratory Acidosis
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Carbon Dioxide efficacy:
  • (isoflurane)
  • (fentanyl)


Intestinal Ischaemia
In this report, Carbon Dioxide was administered for the following condition: pneumoperitoneum.A 36-year-old male consumer from GB (weight: NA) started Carbon Dioxide treatment (dosage: Procedure Took 50 Minutes) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Intestinal Ischaemia
A possible interaction with other drugs could have contributed to this reaction: NA.The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Carbon Dioxide treatment could be related to the listed above side effect(s).

Traumatic Liver Injury, Procedural Complication, Urticaria, Rash Pruritic, Abdominal Pain Upper, Nausea, Retching, Abdominal Distension
This is a report of the following Carbon Dioxide side effect(s):
  • Traumatic Liver Injury
  • Procedural Complication
  • Urticaria
  • Rash Pruritic
  • Abdominal Pain Upper
  • Nausea
  • Retching
  • Abdominal Distension
A 55-year-old female patient from AU (weight: NA) presented with the following condition: pneumoperitoneum and received a treatment with Carbon Dioxide (dosage: NA) starting: May 07, 1993.The following concurrently used drugs could have generated interactions:
  • Heparin
  • Antibiotics
The patient was hospitalized.This report suggests that a Carbon Dioxide treatment could be associated with the listed above side effect(s).

Intestinal Ischaemia, Renal Failure, Abdominal Sepsis, Intestinal Anastomosis Complication, Post Procedural Complication, Surgical Procedure Repeated, Ileal Gangrene, Colon Gangrene
This Carbon Dioxide report was submitted by a 68-year-old male consumer from DE (weight: NA). The patient was diagnosed with: pneumoperitoneum and Carbon Dioxide was administered (dosage: Preocedure Lasted For 85 Min) starting: NS. The consumer developed a set of symptoms:
  • Intestinal Ischaemia
  • Renal Failure
  • Abdominal Sepsis
  • Intestinal Anastomosis Complication
  • Post Procedural Complication
  • Surgical Procedure Repeated
  • Ileal Gangrene
  • Colon Gangrene
Other drugs used simultaneously:
  • Halotane
The patient was hospitalized.Those unexpected symptoms could be linked to a Carbon Dioxide treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Small Intestine Gangrene, Post Procedural Complication
This is a report of a possible correlation between Carbon Dioxide use and the following symptoms/side effect(s):
  • Small Intestine Gangrene
  • Post Procedural Complication
which could contribute to an assessment of Carbon Dioxide risk profile.A 72-year-old female consumer from US (weight: NA) was suffering from pneumoperitoneum and was treated with Carbon Dioxide (dosage: NA) starting NS.Other concurrent medications:
  • Isoflurane


Necrosis Ischaemic, Acute Abdomen, Atrial Fibrillation, Hypotension, Abdominal Adhesions, Intestinal Perforation, Systemic Candida, Neuropathy Peripheral, Pneumonia
A 34-year-old female patient from US (weight: NA) presented with the following symptoms: laparoscopy and after a treatment with Carbon Dioxide (dosage: Less Than 75 Minutes) experienced the following side effect(s):
  • Necrosis Ischaemic
  • Acute Abdomen
  • Atrial Fibrillation
  • Hypotension
  • Abdominal Adhesions
  • Intestinal Perforation
  • Systemic Candida
  • Neuropathy Peripheral
  • Pneumonia
The treatment was started on NS. Carbon Dioxide was used in combination with the following drugs:
  • Sevoflurane
  • Nitrous Oxide
The patient was hospitalized.This report could alert potential Carbon Dioxide consumers.

Air Embolism, Monoplegia
In this report, a 67-year-old male patient from US (weight: NA) was affected by a possible Carbon Dioxide side effect.The patient was diagnosed with NA. After a treatment with Carbon Dioxide (dosage: Total, start date: NS), the patient experienced the following side effect(s):
  • Air Embolism
  • Monoplegia
The following simultaneously used drugs could have led to this reaction:
  • (iodixanol) 50 Ml
The findings here stress that side effects should be taken into consideration when evaluating a Carbon Dioxide treatment.

Sensory Loss, Motor Dysfunction, Paralysis
This is a report of a 67-year-old male patient from US (weight: NA), who used Carbon Dioxide (dosage: NA) for a treatment of angiogram. After starting a treatment on NS, the patient experienced the following side effect(s):
  • Sensory Loss
  • Motor Dysfunction
  • Paralysis
The following drugs could possibly have interacted with the Carbon Dioxide treatment NA.The patient was hospitalized.Taken together, these observations suggest that a Carbon Dioxide treatment could be related to side effect(s), such as Sensory Loss, Motor Dysfunction, Paralysis.

Abdominal Pain Lower, Post Procedural Complication, Vomiting, Colitis Ischaemic, Suprapubic Pain, White Blood Cell Count Increased, Shift To The Left, Computerised Tomogram Abnormal
This abdominal pain lower side effect was reported by a consumer or non-health professional from US. A 75-year-old male patient (weight:NA) experienced the following symptoms/conditions: angiogram. The patient was prescribed Carbon Dioxide (dosage: NA), which was started on NS. Concurrently used drugs: NA. When starting to take Carbon Dioxide the consumer reported the following symptoms:
  • Abdominal Pain Lower
  • Post Procedural Complication
  • Vomiting
  • Colitis Ischaemic
  • Suprapubic Pain
  • White Blood Cell Count Increased
  • Shift To The Left
  • Computerised Tomogram Abnormal
These side effects may potentially be related to Carbon Dioxide.

Carbon Monoxide Poisoning
This is a Carbon Monoxide side effect report of a 87-year-old male patient (weight:NA) from BELGIUM, suffering from the following symptoms/conditions: NA, who was treated with Carbon Monoxide (dosage:NA, start time: NS), combined with:
  • Duragesic-100 (2x100 Ug/hr + 4x50 Ug/hr Patches)
  • Zolpidem
, and developed a serious reaction and a carbon monoxide poisoning side effect. The patient presented with:
  • Carbon Monoxide Poisoning
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Carbon Monoxide treatment in male patients suffering from NA, resulting in carbon monoxide poisoning.

Completed Suicide
This report suggests a potential Carbon Black completed suicide side effect(s) that can have serious consequences. A 51-year-old female patient from UNITED STATES (weight:NA) was diagnosed with the following health condition(s): NA and used Carbon Black (dosage: Unk Ukn, Unk) starting NS. Soon after starting Carbon Black the patient began experiencing various side effects, including:
  • Completed Suicide
Drugs used concurrently:
  • Clozapine (Unk Ukn, Unk)
Although Carbon Black demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as completed suicide, may still occur.

Completed Suicide
This completed suicide problem was reported by a physician from UNITED STATES. A 82-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): NA.On NS a consumer started treatment with Carbon Monoxide (dosage: NA). The following drugs/medications were being taken at the same time:
  • Carbamazepine
  • Laxatives
  • Diazepam
When commencing Carbon Monoxide, the patient experienced the following unwanted symptoms /side effects:
  • Completed Suicide
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as completed suicide, may become evident only after a product is in use by the general population.

Cardiac Arrest, Completed Suicide, Respiratory Arrest, Poisoning
This is a Carbon Monoxide side effect report of a 82-year-old male patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: NA and was treated with Carbon Monoxide (dosage: (df Resipiratory (inhalation))) starting NS. Concurrently used drugs:
  • Diazepam ((df))
  • Laxative (stimulant) ((df))
  • Carbamazepine ((df))
Soon after that, the consumer experienced the following of symptoms:
  • Cardiac Arrest
  • Completed Suicide
  • Respiratory Arrest
  • Poisoning
This opens a possibility that Carbon Monoxide could cause cardiac arrest and that some male patients may be more susceptible.

Completed Suicide, Cardio-respiratory Arrest
A 49-year-old patient (weight: NA) from UNITED STATES with the following symptoms: NA started Carbon Monoxide treatment (dosage: Unk, Unk) on NS. Soon after starting Carbon Monoxide treatment, the consumer experienced several side effects, including:
  • Completed Suicide
  • Cardio-respiratory Arrest
. Concurrently used drugs:
  • Acetaminphen And Codeine Phosphate (Unk, Unk)
  • Bupropion Hcl (Unk, Unk)
This finding indicates that some patients can be more vulnerable to developing Carbon Monoxide side effects, such as completed suicide.

Cardio-respiratory Arrest
This cardio-respiratory arrest side effect was reported by a health professional from UNITED STATES. A 4-year-old patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Carbon Monoxide/smoke (dosage: Unk), which was started on NS. Concurrently used drugs:
  • Midazolam Hydrochloride (Unk, Unk)
.When starting to take Carbon Monoxide/smoke the consumer reported symptoms, such as:
  • Cardio-respiratory Arrest
These side effects may potentially be related to Carbon Monoxide/smoke.

Cardio-respiratory Arrest, Completed Suicide
This is a report of a 51-year-old patient (weight: NA) from UNITED STATES, suffering from the following symptoms/conditions: NA, who was treated with Carbon Monoxide (dosage: Unk, Unk, start time: NS), combined with:
  • Fluoxetine (Unk, Unk)
  • Olanzapine (Unk, Unk)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Cardio-respiratory Arrest
  • Completed Suicide
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Carbon Monoxide treatment in patients, resulting in cardio-respiratory arrest side effect.

Migraine, Abasia, Pain In Extremity, Post Thrombotic Syndrome, Deep Vein Thrombosis, Oedema Peripheral
This report suggests a potential Carbonyl Iron [iron Pentacarbonyl] Migraine, Abasia, Pain In Extremity, Post Thrombotic Syndrome, Deep Vein Thrombosis, Oedema Peripheral side effect(s) that can have serious consequences. A 15-year-old female patient (weight: NA) from UNITED STATES was diagnosed with the following symptoms/conditions: NA and used Carbonyl Iron [iron Pentacarbonyl] (dosage: NA) starting Jan 01, 2008. Soon after starting Carbonyl Iron [iron Pentacarbonyl] the patient began experiencing various side effects, including:
  • Migraine
  • Abasia
  • Pain In Extremity
  • Post Thrombotic Syndrome
  • Deep Vein Thrombosis
  • Oedema Peripheral
Drugs used concurrently:
  • Magnesium Sulfate
  • Hyoscyamine
  • Ibuprofen
  • Codeine Sulfate
  • Miralax
  • Librax (Unk Unk, Tid)
  • Hydromorphone Hcl (24 Mg (daily Dose), Q4hr, Intravenous)
  • Pantoprazole
The patient was hospitalized and became disabled. Although Carbonyl Iron [iron Pentacarbonyl] demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as migraine, may still occur.

Carbon Monoxide Poisoning, Cardiac Arrest, Thermal Burn, Respiratory Arrest
This Carbon Monoxide Poisoning, Cardiac Arrest, Thermal Burn, Respiratory Arrest problem was reported by a physician from UNITED STATES. A 54-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Carbon Monoxide (no Pref. Name) (dosage: Po). The following drugs were being taken at the same time:
  • Oxycontin (Po)
When commencing Carbon Monoxide (no Pref. Name), the patient experienced the following unwanted symptoms/side effects:
  • Carbon Monoxide Poisoning
  • Cardiac Arrest
  • Thermal Burn
  • Respiratory Arrest
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as carbon monoxide poisoning, may become evident only after a product is in use by the general population.

Completed Suicide
This is a report of a 81-year-old male patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: NA and was treated with Carbon Black (dosage: Unk, Unk) starting NS. Concurrently used drugs:
  • Acetaminophen (Unk)
Soon after that, the consumer experienced the following side effects:
  • Completed Suicide
This opens a possibility that Carbon Black treatment could cause the above reactions, including completed suicide, and some male subjects may be more susceptible.

Cardio-respiratory Arrest
A 27-year-old male patient (weight: NA) from UNITED STATES with the following symptoms/conditions: NA started Carbon Monoxide treatment (dosage: NA) on NS. Soon after starting Carbon Monoxide treatment, the subject experienced various side effects, including:
  • Cardio-respiratory Arrest
Concurrently used drugs:
  • Fentanyl-100
This finding indicates that some male patients could be more vulnerable to Carbon Monoxide.

1 of 2 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Carbon Side Effects

    Did You Have a Carbon Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Carbon for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Carbon Safety Alerts, Active Ingredients, Usage Information

    NDC0054-0020
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameLithium Carbonate
    NameLithium Carbonate
    Dosage FormTABLET, EXTENDED RELEASE
    RouteORAL
    On market since20040105
    LabelerRoxane Laboratories, Inc
    Active Ingredient(s)LITHIUM CARBONATE
    Strength(s)450
    Unit(s)mg/1
    Pharma ClassMood Stabilizer [EPC]

    More About Carbon

    Side Effects reported to FDA: 31

    Carbon safety alerts: 2013 2010 2007 2004 2001 2000

    Reported deaths: 8

    Reported hospitalizations: 8

    Sodium Bicarbonate Injection, USP, 7.5% and 8.4%, 50 mL Single Dose Vials - Recall Due to Particulates in Some Vials

    [Posted 12/29/2010]

     

    AUDIENCE: Hospital Risk Managers, Pharmacy, Emergency Medicine

    ISSUE: American Regent and FDA notified healthcare professionals of the nationwide recall of  specific lots of Sodium Bicarbonate Injection, USP, 7.5% and 8.4%, 50 mL Single Dose Vials because some vials of these lots contain particulates. Potential adverse events after intravenous administration include damage to blood vessels in the lung, localized swelling, and granuloma formation.

    BACKGROUND: Sodium Bicarbonate Injection, USP, is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Sodium bicarbonate is further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of blood pigments. Sodium bicarbonate is also indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate.

    RECOMMENDATION: Hospitals, infusion centers, clinics and other healthcare facilities should not use American Regent Inc., Sodium Bicarbonate Injection, USP, 7.5% and 8.4%, 50 mL Single Dose Vials with the lot #s list in the firm press release for patient care and should immediately quarantine any product for return.

    Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

    • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
    • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

     

    [12/28/2010 - Firm Press Release - American Regent]

    Latest Carbon clinical trials